{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial of Lateral Lymph Node Involvement in Rectal Cancer"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "A post hoc analysis of the OPRA trial, a multicenter randomised controlled trial, was conducted."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included rectal cancer with LLN involvement."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients with locally advanced rectal cancer were treated with total neoadjuvant therapy (TNT) followed by total mesorectal excision or watch-and-wait management."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study assesses LLN involvement in rectal adenocarcinoma patients."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was disease recurrence, assessed over a follow-up period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was centralised, with allocation concealment."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding details were not provided."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of 324 patients, 57 (18%) had visible LLN (LLN+) on baseline MRI."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Post-TNT, LLN disappeared in 30 (53%) of these patients."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Disease recurrence in LLN was rare, occurring in 3.5% of LLN+ and 0.4% of LLN\u2212 patients."
      },
      "Harms": {
        "score": 0,
        "evidence": "Adverse events were not reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source]."
      }
    },
    "total_score": 15,
    "max_score": 25
  },
  "model": "gpt-4o"
}